4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-22-063416
CEO & Chief Scientific Officer sold 108,776 shares at an average $34.00 ($3,697,861)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Scientific Officer | 2022-05-18 | Sale | −55,264 | $33.97 | $1,877,395 | 2,168,305 | D |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2022-05-18 | Sale | −9,776 | $34.77 | $339,926 | 2,158,529 | D |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2022-05-18 | Sale | −2,006 | $35.78 | $71,779 | 2,156,523 | D |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2022-05-19 | Sale | −41,615 | $33.76 | $1,404,818 | 2,114,908 | D |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2022-05-19 | Sale | −115 | $34.28 | $3,942 | 2,114,793 | D |
| Open-market sales · 108,776 sh · avg $34.00 · $3,697,861 | |||||||
Loading xslF345X03/tm2215971d4_4seq1.xml…